183 related articles for article (PubMed ID: 6512980)
1. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space].
Cho N; Kimura T; Suzuki H; Fukunaga K; Kunii K; Komoriyama Y
Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980
[TBL] [Abstract][Full Text] [Related]
2. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Cho N; Watanabe H; Yoshida K; Moriyama S; Takeda H; Tsukamoto A; Fukunaga K; Kunii K
Jpn J Antibiot; 1984 Oct; 37(10):1939-55. PubMed ID: 6094873
[TBL] [Abstract][Full Text] [Related]
3. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
[TBL] [Abstract][Full Text] [Related]
4. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Ito K; Kondo H; Hayasaki M; Noda K
Jpn J Antibiot; 1984 Nov; 37(11):2193-202. PubMed ID: 6098712
[TBL] [Abstract][Full Text] [Related]
5. [Studies on sulbactam/cefoperazone in the field of pediatrics].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
[TBL] [Abstract][Full Text] [Related]
6. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
Fujii R; Meguro H; Arimasu O; Mashiko J; Tajima T; Nonaka C; Nagamatsu I; Sato Y; Honjo T; Watanabe A
Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739
[TBL] [Abstract][Full Text] [Related]
7. [Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics].
Toyonaga Y; Kurosu Y; Nakamura H; Sugita M; Takahashi T; Hori M
Jpn J Antibiot; 1984 Dec; 37(12):2457-77. PubMed ID: 6098740
[TBL] [Abstract][Full Text] [Related]
8. [Laboratory and clinical studies of sulbactam/cefoperazone in the pediatric field].
Nishimura T; Tabuki K; Takashima T; Takagi M
Jpn J Antibiot; 1984 Oct; 37(10):1880-92. PubMed ID: 6094866
[TBL] [Abstract][Full Text] [Related]
9. [Effects of sulbactam on the activity of cefoperazone against various clinical isolates].
Uete T; Matsuo K
Jpn J Antibiot; 1989 Apr; 42(4):896-909. PubMed ID: 2769941
[TBL] [Abstract][Full Text] [Related]
10. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
Jpn J Antibiot; 1984 Oct; 37(10):1898-918. PubMed ID: 6094868
[TBL] [Abstract][Full Text] [Related]
11. [Transfer of injected sulbactam/cefoperazone into burn blister fluid].
Aoyama H; Sugiyama H; Tada M; Okuda J; Izawa Y
Jpn J Antibiot; 1988 Sep; 41(9):1279-84. PubMed ID: 3241326
[TBL] [Abstract][Full Text] [Related]
12. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
Uete T; Matsuo K
Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
[TBL] [Abstract][Full Text] [Related]
13. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Yamamoto T; Yasuda J; Kanao M; Okada H
Jpn J Antibiot; 1984 Nov; 37(11):2213-22. PubMed ID: 6098715
[TBL] [Abstract][Full Text] [Related]
14. [Studies on antimicrobial concentrations of flomoxef in serum, pelvic dead space exudate, and pelvic organs/tissues].
Obata T; Koishi K; Sasaki J; Eguchi M; Yamamoto Y
Jpn J Antibiot; 1987 Oct; 40(10):1820-9. PubMed ID: 3444023
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
[TBL] [Abstract][Full Text] [Related]
16. [Fundamental studies on aspoxicillin in the field of gynecology. Penetration of the drug into the genital organs and the dead space fluid. Antibacterial activity of the drug against various strains of clinical isolates].
Takase Z; Shirafuji H; Maki M; Seki M; Cho N; Noda K; Hayasaki M; Itoh K; Hasegawa Y; Ninomiya K
Jpn J Antibiot; 1985 Jul; 38(7):1979-2002. PubMed ID: 3851864
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic, bacteriological and clinical studies of cefuzonam in the field of obstetrics and gynecology].
Ito K; Iida K; Kondo H; Noda K; Hayasaki M; Sumi H; Kadomoto N
Jpn J Antibiot; 1987 May; 40(5):1066-73. PubMed ID: 3669285
[TBL] [Abstract][Full Text] [Related]
18. [Fundamental and clinical studies of sulbactam/cefoperazone in the field of pediatrics].
Nakazawa S; Sato H; Narita A; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K
Jpn J Antibiot; 1984 Nov; 37(11):2174-87. PubMed ID: 6098710
[TBL] [Abstract][Full Text] [Related]
19. [Fundamental study of ceftriaxone in the field of obstetrics and gynecology].
Itoh K; Kondoh H; Hayasaki M; Noda K
Jpn J Antibiot; 1984 Dec; 37(12):2343-8. PubMed ID: 6098727
[TBL] [Abstract][Full Text] [Related]
20. [Clinical studies of cefoperazone in neurosurgery].
Kitamura K; Shimizu T; Abe H; Suzuki J; Tanaka R; Nagai H; Yamamoto S; Handa H; Nishimoto A; Matsuoka K
Jpn J Antibiot; 1986 Jan; 39(1):63-74. PubMed ID: 2939268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
